The AI model, a convolutional neural network, could help age-based risk scores be more accurate than ever before.
The new AI tool can be used alongside GE Healthcare’s full line of Venue ultrasound systems, including the new Venue Fit.
The analysis, published in Circulation: Cardiovascular Quality and Outcomes, included data from more than 87,000 Medicare patients.
Tracking a patient's longitudinal strain and circumferential strain may improve the ability to predict their risk of heart failure later in life.
The analysis, published in JACC: Cardiovascular Imaging, included clinical data and non-contrast CT findings from more than 66,000 patients.
The new study, published in JAMA Cardiology, included more than 800 hypertension patients aged 75 years or older.
These latest findings are based on data from the VERDICT trial.
Researchers see their AI model as a way to improve patient access to important imaging exams.
A team of cardiologists and radiologists explored the issue, sharing their findings in JAMA Cardiology.
“Importantly, the pattern of damage to the heart was variable, suggesting that the heart is at risk of different types of injury,” one researcher said.
Intelerad Medical Systems has acquired Lumedx, an Oakland, California-based healthcare technology company focused on analytics and cardiovascular information systems. This is Intelerad’s third acquisition in the last seven months.
The guidance, published in full in the Journal of Cardiovascular Computed Tomography, includes updates to previous CCTA recommendations and was designed to answer common questions.